Your session is about to expire
← Back to Search
Perceptual Learning Study in Sensory and Motor Function
N/A
Recruiting
Led By Hannah Block
Research Sponsored by Indiana University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Ages of 18-45 years old
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights
Study Summary
This trial is studying how the brain helps us keep our hand movements accurate. The findings could improve rehabilitation techniques for people with brain lesions.
Who is the study for?
This trial is for right-handed individuals aged 18-45, free of COVID symptoms and fully vaccinated or with a recent negative test. Exclusions include BMI over 30, inability to perform tasks or follow instructions, IUD users without MR compatibility confirmation, claustrophobia, pregnancy, vision issues not correctable by MRI-compatible glasses at the center, neurological disorders or upper limb conditions.Check my eligibility
What is being tested?
The study aims to explore how sensory and motor brain areas collaborate during hand movement learning. Participants will engage in perceptual learning while their brain function is monitored. The goal is to gather insights that could enhance rehabilitation methods for patients with brain damage.See study design
What are the potential side effects?
Since this study involves non-invasive techniques like functional MRI scanning and perceptual tasks rather than medication or surgery, side effects are minimal but may include discomfort from lying still in the scanner for extended periods.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am between 18 and 45 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 day
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Reaching task performance
Resting state functional connectivity
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Perceptual learningExperimental Treatment1 Intervention
Reaching task in which visual information about target finger position is offset to induce a change in perception of the finger.
Group II: ControlActive Control1 Intervention
Reaching task with accurate visual information.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Perceptual learning
2004
N/A
~70
Find a Location
Who is running the clinical trial?
Indiana UniversityLead Sponsor
980 Previous Clinical Trials
981,681 Total Patients Enrolled
3 Trials studying Basic Science
700 Patients Enrolled for Basic Science
National Institute of Neurological Disorders and Stroke (NINDS)NIH
1,341 Previous Clinical Trials
649,269 Total Patients Enrolled
3 Trials studying Basic Science
700 Patients Enrolled for Basic Science
Hannah BlockPrincipal InvestigatorIndiana University, Bloomington
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I can follow instructions and perform tasks during the study.I've had symptoms like those of Covid in the past week and am not fully vaccinated or haven't tested negative in the past 4 days.I cannot stay still for long or am claustrophobic.I have a history of nerve, bone, or pain issues in my arms.My BMI is over 30.I have not had COVID-19 symptoms in the last week.I am between 18 and 45 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Perceptual learning
- Group 2: Control
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Could I potentially join this research project?
"This study is open to any individuals with a passing knowledge of science and an age between 18-45. The team expects to accept close to 120 participants in total."
Answered by AI
Does the current trial have an age cap, and if so, what is that limit?
"To be considered for this trial, potential patients must meet the age criteria of 18 years or above and 45 years or below."
Answered by AI
How many individuals are enrolled in the research project?
"Accurately, clinicaltrials.gov demonstrates that this trial is presently enrolling participants. It was announced in April 2022 and it's most recent update occurred on October 13th of the same year. The study requires 120 individuals from one location to partake."
Answered by AI
Are there currently opportunities for enrollment in this clinical trial?
"Indeed, the information accessible on clinicaltrials.gov reveals that this medical research is presently looking for participants to join in. The trial was initially posted back on April 13th 2022 and most recently updated on October 13th 2022. 120 subjects are sought from a single site of recruitment."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger